Log in

OTCMKTS:LXRPLexaria Bioscience SEC Filings & 10K Form

$0.28
-0.02 (-5.46 %)
(As of 06/4/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.28
Now: $0.28
$0.29
50-Day Range
$0.25
MA: $0.30
$0.39
52-Week Range
$0.22
Now: $0.28
$1.00
Volume328,532 shs
Average Volume112,315 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

SEC Filings

Lexaria Bioscience (OTCMKTS:LXRP) SEC Filings

DateFilerForm TypeView
06/04/2020
4:16 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2020
4:02 PM
Lexaria Bioscience (Filer)
Form S-1
Registration statement under Securities Act of 1933  
05/26/2020
12:30 PM
Lexaria Bioscience (Filer)
Form DEF 14A
05/13/2020
11:30 AM
Lexaria Bioscience (Filer)
Form D
Notice of Exempt Offering of Securities 
05/13/2020
11:12 AM
Lexaria Bioscience (Filer)
Form PRE 14A
05/08/2020
6:05 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2020
3:26 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2020
1:09 PM
Lexaria Bioscience (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
1:00 PM
Baxter Nicholas W (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
12:40 PM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
12:30 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
12:04 PM
Lexaria Bioscience (Issuer)
Quigley Brian W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2020
11:49 AM
Lexaria Bioscience (Issuer)
Spissinger Allan Horst (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
1:34 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
1:23 PM
Lexaria Bioscience (Issuer)
Spissinger Allan Horst (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
12:43 PM
Lexaria Bioscience (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
12:13 PM
Lexaria Bioscience (Issuer)
Quigley Brian W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
11:56 AM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2020
11:23 AM
Baxter Nicholas W (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2020
10:10 AM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2020
12:13 PM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/22/2020
1:47 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/09/2020
2:43 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/30/2019
4:26 PM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
10:52 AM
Baxter Nicholas W (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:27 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2019
12:16 PM
Lexaria Bioscience (Filer)
Form D
Notice of Exempt Offering of Securities 
11/18/2019
3:37 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2019
5:14 AM
Lexaria Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/13/2019
1:06 PM
Lexaria Bioscience (Filer)
Form D
Notice of Exempt Offering of Securities 
08/16/2019
11:34 AM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2019
10:46 AM
Lexaria Bioscience (Issuer)
Quigley Brian W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2019
12:34 PM
Baxter Nicholas W (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
3:56 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/06/2019
12:05 PM
Lexaria Bioscience (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2019
1:34 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/11/2019
11:45 AM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2019
5:25 AM
Lexaria Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/21/2019
3:21 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2019
11:34 AM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2019
9:19 AM
Lexaria Bioscience (Filer)
Form DEF 14A
05/21/2019
11:20 AM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/17/2019
3:57 PM
Lexaria Bioscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
05/09/2019
12:45 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/30/2019
1:21 PM
Lexaria Bioscience (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/25/2019
12:00 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2019
4:57 PM
Baxter Nicholas W (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:43 PM
Lexaria Bioscience (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2019
4:31 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2019
1:39 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2019
2:56 PM
Lexaria Bioscience (Filer)
Form CT ORDER
02/15/2019
1:06 PM
Lexaria Bioscience (Issuer)
Spissinger Allan Horst (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
2:06 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2019
3:28 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2019
4:09 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/11/2019
3:37 PM
Lexaria Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
12/19/2018
3:01 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2018
1:38 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2018
3:29 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2018
4:14 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2018
3:24 PM
Lexaria Bioscience (Filer)
Form D
Notice of Exempt Offering of Securities 
11/14/2018
1:14 PM
Lexaria Bioscience (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
11/06/2018
12:58 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/19/2018
2:58 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2018
4:00 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
3:29 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2018
3:56 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2018
3:16 PM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2018
2:57 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
11:35 AM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2018
2:31 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2018
2:05 PM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2018
4:16 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/13/2018
5:09 AM
Lexaria Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/05/2018
2:31 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2018
1:08 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/19/2018
2:19 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
1:03 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/01/2018
2:06 PM
Baxter Nicholas W (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
5:13 PM
Lexaria Bioscience (Issuer)
Spissinger Allan Horst (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
3:00 PM
Lexaria Bioscience (Issuer)
McKechnie William Edward (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
1:42 PM
BUNKA CHRISTOPHER (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2018
1:25 PM
DOCHERTY JOHN MARTIN (Reporting)
Lexaria Bioscience (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/25/2018
1:58 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/26/2018
1:23 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2018
6:36 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/12/2018
4:21 PM
Lexaria Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/09/2018
3:55 PM
Lexaria Bioscience (Filer)
Form 424B3
03/28/2018
3:49 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/23/2018
2:43 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/16/2018
4:04 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2018
11:15 PM
Lexaria Bioscience (Filer)
Form EFFECT
03/02/2018
12:44 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/06/2018
4:07 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/12/2018
2:36 PM
Lexaria Bioscience (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
01/09/2018
3:01 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2018
4:26 PM
Lexaria Bioscience (Filer)
Form S-4
Registration statement under Securities Act of 1933  
12/22/2017
6:12 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2017
3:15 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2017
2:44 PM
Lexaria Bioscience (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 6/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.